Organ Transplant Immunosuppressant Drugs Market Size, Share & Trends Analysis Report By Drug Class (Calcineurin Inhibitors, Antiproliferative Agents), By Transplant Type, By Region, And Segment Forecasts, 2025 - 2030

Organ Transplant Immunosuppressant Drugs Market Size, Share & Trends Analysis Report By Drug Class (Calcineurin Inhibitors, Antiproliferative Agents), By Transplant Type, By Region, And Segment Forecasts, 2025 - 2030


Fishing Rods Market Growth & Trends

The global fishing rods market size is estimated to reach USD 1.77 billion by 2030, expanding at a CAGR of 6.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing adoption of angling as a hobby is creating a drift in the market. Furthermore, angling is getting a commercial focus from the current business operating across the entire aquaculture sector.

Along with the manufacturers innovating the products, a constant strategic action by these companies has been witnessed in the industry. Over the past few years, the rod manufacturers have been organizing large fishing festivals. Use of social media helps in propagating the news and thus, create an interest among the beginners for angling as a recreational activity, thereby promoting the use of rods.

These manufacturers are also hosting and sponsoring some of the largest angling competitions in the world annually, where thousands of anglers participate and love to showcase their angling skills. Fishing has also become a rescue from the busy and noisy city life for its practitioners. The calm and serene environment around the water reservoirs and an opportunity to practice a peaceful art are attracting people towards angling. People have started taking fishing centered vacations, where they spend a majority their time performing the activity. This, in turn, is driving the global fishing rods market.

Some of the key players are AFTCO Mfg.; Cabela’s Inc.; Dongmi; Eagle Claw; Preston Innovations; RYOBI; Shakespeare; Shimano; St. Croix; Tica; Tiemco; and Weihai Guangwei Group. Product innovation seems to be the most central strategy for the manufacturers. Myriads of products are available in the market to cater to unique demands of every angler from light weight to heavy weight rods as well as from slow action to very fast action rods. These products have been innovated on the basis of the reservoir one prefers to catch fish in, as there are different rods for ice, freshwater, and saltwater fishing. Moreover, innovation has been done on the basis of one interest in angling a certain kind of fish depending on its shape, size, and weight.

Fishing Rods Market Report Highlights
  • By product, Spinning rods dominated the market with a revenue share of 36.0% in 2024, driven by their user-friendly design and versatility.
  • By raw material, Carbon fiber held the largest market share of 50.7% in 2024, fueled by the exceptional strength-to-weight ratio of carbon fiber rods, which are lightweight yet durable.
  • The recreational application segment accounted for more than 45.8% share of the global revenue in 2018.
  • Commercial fishing is expected to register the fastest CAGR of 6.7% over the forecast period.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug Class
1.2.2. Transplant Type
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Organ Transplant Immunosuppressant Drugs Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. Organ Transplant Immunosuppressant Drugs Market: Drug Class Business Analysis
4.1. Drug Class Market Share, 2024 & 2030
4.2. Drug Class Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2018 to 2030 (USD Million)
4.4. Calcineurin Inhibitors
4.4.1. Calcineurin Inhibitors Market, 2018 - 2030 (USD Million)
4.5. Antiproliferative Agents
4.5.1. Antiproliferative Agents Market, 2018 - 2030 (USD Million)
4.6. mTOR Inhibitor
4.6.1. mTOR Inhibitor Market, 2018 - 2030 (USD Million)
4.7. Steroids
4.7.1. Steroids Market, 2018 - 2030 (USD Million)
4.8. Other Drug Classes
4.8.1. Other Drug Classes Market, 2018 - 2030 (USD Million)
Chapter 5. Organ Transplant Immunosuppressant Drugs Market: Transplant Type Business Analysis
5.1. Transplant Type Market Share, 2024 & 2030
5.2. Transplant Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Transplant Type, 2018 to 2030 (USD Million)
5.4. Kidney
5.4.1. Kidney Market, 2018 - 2030 (USD Million)
5.5. Liver
5.5.1. Liver Market, 2018 - 2030 (USD Million)
5.6. Heart
5.6.1. Heart Market, 2018 - 2030 (USD Million)
5.7. Lung
5.7.1. Lung Market, 2018 - 2030 (USD Million)
5.8. Pancreas
5.8.1. Pancreas Market, 2018 - 2030 (USD Million)
5.9. Other Transplant Types
5.9.1. Other Transplant Types Market, 2018 - 2030 (USD Million)
Chapter 6. Organ Transplant Immunosuppressant Drugs Market: Regional Estimates & Trend Analysis by Drug Class and Transplant Type
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Canada Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. Mexico Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework
6.5.2.3. Competitive Insights
6.5.2.4. UK Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework
6.5.3.3. Competitive Insights
6.5.3.4. Germany Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework
6.5.4.3. Competitive Insights
6.5.4.4. France Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Regulatory Framework
6.5.5.3. Competitive Insights
6.5.5.4. Italy Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Regulatory Framework
6.5.6.3. Competitive Insights
6.5.6.4. Spain Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.7. Norway
6.5.7.1. Key Country Dynamics
6.5.7.2. Regulatory Framework
6.5.7.3. Competitive Insights
6.5.7.4. Norway Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key Country Dynamics
6.5.8.2. Regulatory Framework
6.5.8.3. Competitive Insights
6.5.8.4. Denmark Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.9. Sweden
6.5.9.1. Key Country Dynamics
6.5.9.2. Regulatory Framework
6.5.9.3. Competitive Insights
6.5.9.4. Sweden Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework
6.6.2.3. Competitive Insights
6.6.2.4. Japan Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework
6.6.3.3. Competitive Insights
6.6.3.4. China Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework
6.6.4.3. Competitive Insights
6.6.4.4. India Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework
6.6.5.3. Competitive Insights
6.6.5.4. Australia Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework
6.6.6.3. Competitive Insights
6.6.6.4. South Korea Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Framework
6.6.7.3. Competitive Insights
6.6.7.4. Thailand Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework
6.7.3.3. Competitive Insights
6.7.3.4. Argentina Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Framework
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Regulatory Framework
6.8.4.3. Competitive Insights
6.8.4.4. UAE Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Regulatory Framework
6.8.5.3. Competitive Insights
6.8.5.4. Kuwait Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Astellas Pharma d.o.o.
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Sanofi
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Accord Healthcare
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Novartis AG
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Viatris Inc.
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. F. Hoffmann-La Roche Ltd
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. GlaxoSmithKline plc.
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Veloxis Pharmaceuticals, Inc.
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Bristol-Myers Squibb Company
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings